Researchers create an AI model integrating genetic, clinical, and transcriptomic data to identify individuals at risk for thrombosis.
Key Details
- 1A new AI tool analyzes over 12,900 genes alongside clinical and genetic data to model thrombosis risk.
- 2Study involved 790 individuals from families with a history of venous thrombosis, including 70 with idiopathic thrombosis.
- 3494 genes, including many noncoding RNAs, were identified as associated with thrombosis risk.
- 4Adding transcriptomic data improved patient classification: those classified 'high-risk' without thrombosis dropped from 43% to 23%.
- 5The research was published in the Journal of Thrombosis and Haemostasis and still requires external validation.
Why It Matters
The study highlights how integrating genomic and transcriptomic profiles via AI can provide more precise risk stratification than clinical factors alone, pointing toward more personalized and data-driven approaches in disease prevention—relevant as similar data integration strategies emerge in radiology and imaging AI.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.